Cantitate/Preț
Produs
Total produse
Vezi coșul
Protein-Protein Interactions de Michael D. Wendt

Protein-Protein Interactions: Topics in Medicinal Chemistry, cartea 8

Editat de Michael D. Wendt
en Limba Engleză Paperback – 18 iul 2014
Michael D. Wendt
Protein-Protein Interactions as Drug Targets
Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics
Kurt Deshayes , Jeremy Murray , Domagoj Vucic
The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer
John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection

Nicholas A. Meanwell , David R. Langley
Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus
Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora
Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces
Michael D. Wendt
The Discovery of Navitoclax, a Bcl-2 Family Inhibitor
 
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 119135 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 18 iul 2014 119135 lei  6-8 săpt.
Hardback (1) 119568 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 28 iun 2012 119568 lei  6-8 săpt.

Din seria Topics in Medicinal Chemistry

Preț: 119135 lei

Preț vechi: 145286 lei
-18% Nou

Puncte Express: 1787
Preț estimativ în valută:
22804€ • 23911$ • 18842£

Carte tipărită la comandă

Livrare economică 30 ianuarie-13 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642439551
ISBN-10: 3642439551
Pagini: 280
Ilustrații: XVIII, 262 p.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.4 kg
Ediția:2012
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Topics in Medicinal Chemistry

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

Protein-Protein Interactions as Drug Targets.- Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics.- The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer.- Protein-Protein Interaction Targets to Inhibit HIV-1 Infection.- Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus.- Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces.- The Discovery of Navitoclax, a Bcl-2 Family Inhibitor.

Textul de pe ultima copertă

Michael D. Wendt
Protein-Protein Interactions as Drug Targets
Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics
Kurt Deshayes , Jeremy Murray , Domagoj Vucic
The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer
John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection

Nicholas A. Meanwell , David R. Langley
Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus
Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora
Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces
Michael D. Wendt
The Discovery of Navitoclax, a Bcl-2 Family Inhibitor

Caracteristici

In each volume an overview chapter introduces the newcomer to the topic covered Series covers hot topics of frontier research summarized by reputed scientists in the field Review series is topic related Includes supplementary material: sn.pub/extras